Bringing a medical device to market starts with defining the right regulatory pathway, and executing it with precision. MethodSense helps you develop and manage regulatory strategies that align with your product’s innovation, business goals, and the expectations of global regulatory bodies. Whether you’re pursuing a 510(k), De Novo, PMA, or CE Marking, our experienced team delivers clarity, speed, and confidence throughout your submission journey.
Regulatory Pathway Consulting
We analyze your product, indications, and risk profile to chart the most effective route to regulatory approval.
Choosing the right regulatory path can influence everything from your development timeline to investor confidence. We help you evaluate available options through a business-focused lens, ensuring your strategy not only meets regulatory expectations but also aligns with product innovation, risk appetite, and long-term goals. Our approach eliminates uncertainty and gives you a clear starting point to build your entire compliance roadmap.
Why MethodSense Matters: We reduce guesswork and help you make informed, strategic choices from day one.
- Identify product classification and optimal regulatory pathway
- Evaluate global submission requirements and timelines
- Clarify indications for use and supporting evidence expectations
- Align regulatory planning with development and funding milestones
Submission Management & Acceleration
We take the pressure off your internal team by managing and streamlining the submission process from start to finish.
The submission process can be overwhelming, especially when it involves multiple contributors, complex technologies, or aggressive timelines. We streamline it by introducing structure, accountability, and automation through our LuminLogic® platform. Whether it’s your first 510(k) or a complex premarket approval (PMA), our team helps ensure that every element is organized, compliant, and submission-ready, so you can move forward with confidence and clarity.
Why MethodSense Matters: Our submission-ready process ensures completeness, consistency, and faster regulatory response times.
- Assemble, review, and format submission content
- Manage document version control and approvals in LuminLogic
- Track timelines and coordinate contributors
- Ensure compliance with FDA eSTAR and MDR structures
Pre-Submission & FDA Negotiations
Early interaction with the FDA sets the tone for your review process. We help you craft a confident, productive strategy for Q-Submissions and agency communication.
Engaging the FDA early can provide critical feedback that saves time and reduces risk later in the process. But it requires the right questions, the right tone, and the right documentation. We prepare you to enter agency conversations with confidence, guiding your team through every step of the Q-Sub process and ensuring that your interactions build trust, not tension, with regulatory reviewers.
Why MethodSense Matters: We help you gain early clarity and establish a collaborative rapport with regulatory reviewers.
- Prepare Pre-Sub packages and FDA meeting questions
- Coach your team for agency presentations and negotiations
- Manage correspondence and follow-up with regulators
- Capture feedback and integrate it into your submission strategy
Cybersecurity & Risk Compliance
Connected devices and software-driven products face heightened scrutiny. We guide your compliance strategy across risk and security domains.
As devices become more connected and software-driven, regulators are raising the bar for security, reliability, and risk transparency. MethodSense ensures you stay ahead of those expectations with detailed documentation, traceable controls, and a risk framework that integrates cybersecurity with your design, labeling, and regulatory narrative. Our guidance helps you protect patients and meet the demands of increasingly complex reviews.
Why MethodSense Matters: We help you proactively manage risk and security, avoiding regulatory delays and postmarket exposure.
- Map cybersecurity controls and software bill of materials (SBOM) documentation
- Align with FDA and global premarket cybersecurity expectations
- Support ISO 14971 risk management planning and documentation
- Connect risk controls to design outputs and labeling
Regulatory Remediation & FDA Audit Support
If you’re facing submission rejections, 483s, or other regulatory actions, MethodSense helps you recover, respond, and rebuild.
When things go off course, whether it’s a rejected submission, a 483 observation, or a surprise audit, MethodSense steps in with the clarity and structure needed to get you back on track. We don’t just fix documentation; we help you understand the root causes, build sustainable improvements, and rebuild trust with regulators. With our support, you can turn compliance setbacks into momentum toward your next milestone.
Why MethodSense Matters: We turn regulatory roadblocks into recoverable moments, fast.
- Assess root causes and remediate documentation
- Draft responses to refuse to accept (RTA), AI requests, or inspection findings
- Support CAPA implementation and verification
- Realign your strategy and prepare for re-submission